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Proteolytic cleavage activation of influenza virus hemagglutinin (HA0) is required for cell entry via receptor-
mediated endocytosis. Despite numerous studies describing bacterial protease-mediated influenza A viral
activation in mammals, very little is known about the role of intestinal bacterial flora of birds in hemagglutinin
cleavage/activation. Therefore, the cloaca of wild waterfowl was examined for (i) representative bacterial types
and (ii) their ability to cleave in a “trypsin-like” manner the precursor viral hemagglutinin molecule (HA0).
Using radiolabeled HA0, bacterial secretion-mediated trypsin-like conversion of HA0 to HA1 and HA2 peptide
products was observed to various degrees in 42 of 44 bacterial isolates suggestive of influenza virus activation
in the cloaca of wild waterfowl. However, treatment of uncleaved virus with all bacterial isolates gave rise to
substantially reduced emergent virus progeny compared with what was expected. Examination of two isolates
exhibiting pronounced trypsin-like conversion of HA0 to HA1 and HA2 peptide products and low infectivity
revealed lipase activity to be present. Because influenza virus possesses a complex lipid envelope, the presence
of lipid hydrolase activity could in part account for the observed less-than-expected level of viable progeny. A
thorough characterization of respective isolate protease HA0 hydrolysis products as well as other resident
activities (i.e., lipase) is ongoing such that the role of these respective contributors in virus activation/
inactivation can be firmly established.
Avian influenza viruses preferentially replicate in cells lining
the intestinal tract, giving rise to little or no sign of disease and
high concentrations of virus in the feces (9, 10, 14, 26–28, 33).
“Trypsin-like” proteolytic cleavage of hemagglutinin (HA0), a
viral glycoprotein located on the surface of the surrounding
viral membrane to HA1 and HA2 peptides is required for entry
of the virus into the cell via receptor-mediated endocytosis
(29). Although viral infection in host cells of the small intes-
tine, colon, and cecum has been demonstrated (13, 14, 27, 33),
the proteases responsible for viral activation remain unknown
(11). Thus, the fundamental question arises—could microbes
present in the lower digestive tract provide proteases capable
of cleaving hemagglutinin much like those found in the avian,
swine, and human respiratory tracts (3, 4, 16, 17, 19, 23, 25, 30,
31)? Several studies have been carried out describing indige-
nous avian intestinal microflora; however, these studies fo-
cused primarily on diseases affecting commercial poultry and
the potential of free-ranging birds to transport and disseminate
pathogenic microorganisms to humans (5, 12, 32). Therefore,
the primary focus of work described in this report assesses
proteolytic cleavage of HA0 by secreted bacterial proteases in
the lower digestive tract of wild ducks. Secondarily, we ob-
served lipase activity in two representative bacterial secretions
that could account for the inability of activated (i.e., proteo-
lytically cleaved) virus to give rise to progeny virus.
MATERIALS AND METHODS
Isolation of protease-secreting bacteria from cloacal samples. Cloacal samples
were collected from 112 hunter-harvested ducks: mallard (Anas platyrhynchos;
n  64), blue-winged teal (Anas discors; n  32), northern pintail (Anas acuta;
n  9), and green-winged teal (Anas carolinensis; n  7). Samples were collected
with sterile cotton fiber swabs, suspended in 1 ml Gram-negative (GN) broth,
and transported to the laboratory. Using a 10-l calibrated loop, samples were
four-quadrant streaked onto a set of agar media selected to allow growth of a
range of bacteria. MacConkey’s agar (Fisher Scientific, Pittsburgh, PA) and
Columbia CNA agar (Fisher Scientific, Pittsburgh, PA) supplemented with 5%
(vol/vol) sheep blood were used to differentiate Gram-negative and Gram-pos-
itive bacteria, respectively. Detection of Gram-negative proteolytic bacteria was
determined by using standard methods caseinate agar (SMCA; Fisher Scientific,
Pittsburgh, PA) (18), with modification of the published recipe by addition of
1.5 g bile salt 3 and 1.0 mg crystal violet. Gram-positive proteolytic organisms
were identified with phenylethyl alcohol (PEA; Fisher Scientific, Pittsburgh, PA)
agar supplemented with 10 g sodium caseinate. Culture plates were incubated
aerobically for 24 to 72 h at 37°C and observed every 24 h. Colonies exhibiting
different morphologies were placed on SMCA and evaluated for proteolytic
activity (18). Proteolytic isolates were streaked for purity on tryptic soy agar
(Fisher Scientific, Pittsburgh, PA) supplemented with 5% (vol/vol) sheep blood.
Identification of protease-secreting bacteria from cloacal samples. Following
Gram staining, isolates were identified using a Vitek 2 Compact automated
identification system (bioMe´rieux, Inc., Durham, NC). For bacterial isolates
identified with confidence levels of 85% or isolates not identified by using the
Vitek 2 Compact system, sequence analysis of 16S rRNA was utilized for iden-
tification (2). Bacterial nucleic acids were isolated with a High Pure PCR tem-
plate preparation kit (Roche Applied Science, Indianapolis, IN). A 1,500-bp
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region coding for 16S rRNA was PCR amplified with the following conserved
primers (Integrated DNA Technologies, Skokie, IL): 8F (5-AGAGTTTGATC
CTGGCTCAG) and 1492R (5-ACGGTTACCTTGTTACGACTT). Each am-
plification mixture contained 24.3 l double-distilled H2O (ddH2O), 5.0 l 10
PCR buffer, 5.0 l primer mix (5 M), 4 l MgCl2 (25 mM), 4 l premixed
deoxynucleoside triphosphates (25 mM each), 2.5 l dimethyl sulfoxide (DMSO)
(100% [vol/vol]), 0.2 l Taq polymerase (5.0 U/l; Fisher Scientific, Pittsburgh,
PA), and 5 l DNA template for a total reaction volume of 50 l. The PCR
cycling conditions consisted of initial denaturation at 95°C for 5 min followed by
30 cycles of 94°C for 1 min, 63°C for 1 min, and 72°C for 1.15 min, with final
extension at 72°C for 10 min. Amplified products were purified by using a High
Pure PCR product purification kit (Roche Applied Science, Indianapolis, IN)
according to the manufacturer’s instructions and sequenced by using an Applied
Biosystems 3730XL DNA analyzer (University of Arizona). 16S rRNA se-
quences were investigated with ChromasLite, and contigs were constructed with
ChromasPro (Technelysium Pty., Ltd.). Sequences were compared with available
GenBank sequences by using the gapped BLASTN 2.2.21 program through the
National Center for Biotechnology Information Server. Identified isolates were
placed in Cryocare Bacterial Preservers (Key Scientific Products, Stamford, TX)
according to the manufacturer’s instructions and stored at 80°C.
Preparation of bacterial supernatants containing secreted proteases. Bacte-
rial isolates were incubated in 15 ml brain heart infusion broth (Fisher Scientific,
Pittsburgh, PA) for 36 to 72 h at 37°C with shaking (250 rpm). Samples were
clarified by centrifugation (9,000  g for 10 min), and supernatant material was
filtered through sterile 0.2-m-pore cellulose acetate membrane syringe filters.
Samples were concentrated to approximately 1 ml by ultrafiltration using Cen-
triprep 10-kDa molecular mass-cutoff concentrators (Millipore, Tullagreen, Ire-
land). Concentrated culture supernatant material was aliquoted (100 l) and
stored at 80°C.
Detection of protease activity in bacterial supernatants. Concentrated bacte-
rial culture supernatants were evaluated for proteolytic activity by agar gel
diffusion. Agar gels contained 25 mM Tris (pH 7.2), 150 mM NaCl, 0.6% (wt/vol)
casein sodium salt, and 1% (wt/vol) Bacto agar poured to a depth of 4 mm
(approximately 23 ml) in 100- by 15-mm petri dishes. Aliquots (10 l) of con-
centrated bacterial culture supernatant material were placed in 3-mm-diameter
wells and incubated for 18 h at 37°C. Plates were overlaid with 3% (vol/vol) acetic
acid, and proteolytic activity was noted as a clear zone or a zone of precipitated
casein products (para--, 	s1-, and 
-caseins) around the sample well. Proteolytic
activity was determined by measuring the diameter of the proteolytic zone
around the respective sample wells. Tosyl-L-phenylalanyl chloromethyl ketone
(TPCK; Sigma-Aldrich, St. Louis, MO) trypsin (10 g/ml) served as a positive
control.
Virus. A low-pathogenicity laboratory-derived reassortant virus construct
(combination of A/Indonesia/5/2005 H5N1 and A/PR8/34 H1N1 viruses) was
kindly provided by Ruben Donis from the Centers for Disease Control and
Prevention and was used for in vitro HA0 cleavage assays and in vivo influenza
virus activation experiments. This virus contains the low-pathogenicity HA0
cleavage site (single basic amino acid) of of A/Indonesia/5/2005 and grows well
in MDCK cell lines.
Uncleaved virus stock preparation. MDCK cells were infected with allantoic
fluid-activated virus at a multiplicity of infection of 1 in virus production–serum-
free medium (VP-SFM; Gibco, NY). After 1 h of incubation, the inoculum was
removed and the cells were washed five times with warm phosphate-buffered
saline (PBS; pH 7.4). Fresh VP-SFM0 was added before incubating the cells for
24 to 48 h. Cell supernatants containing uncleaved virions were initially clarified
by centrifugation at 8,000 rpm (Beckman Alerga 25R, A-10.250 rotor) for 20 min
at 5°C to remove cell debris. The resulting supernatant was concentrated by
centrifugation at 48,000 g for 4 h at 5°C on a sucrose cushion using a precooled
Beckman type 19 rotor and centrifuge. Concentrated virus was collected and
stored at 80°C until needed.
Preparation of radiolabeled HA0. Confluent MDCK cells (American Type
Culture Collection, Manassas, VA) were infected with allantoic fluid-activated
virus at a multiplicity of infection of 1. After allowing viral attachment and
penetration for 1 h, the inoculum was removed and the cells were washed once
with warmed phosphate-buffered saline (PBS). The monolayers were incubated
in a mixture of [35S]methionine and -cysteine (0.1 mCi/ml specific activity; Perkin
Elmer, Waltham, MA) at 37°C with 5% (vol/vol) CO2 overnight. The resulting
cells and supernatant were pelleted by centrifugation at 850  g for 2 min, and
HA0 was extracted with a membrane protein extraction kit (Pierce Protein
Research Products, Rockford, IL) supplemented with 100 l of 10 protease
inhibitor cocktail (Sigma-Aldrich, St. Louis, MO) and 1 mM phenylmethylsul-
fonyl fluoride (PMSF; Sigma-Aldrich, St. Louis, MO) to prevent inadvertent
cleavage of HA0 by liberated cytosolic proteases. Radiolabeled HA0 was immu-
noprecipitated with anti-H5 monoclonal antibodies (Rockland Immunochemi-
cals, Inc., Gilbertsville, PA) linked to Dynabeads-protein A (Invitrogen, Oslo,
Norway) per the manufacturer’s instructions, ensuring all washes were free of
protease inhibitors.
HA0 cleavage assay. [35S]HA0 (4.8 nCi, 10,600 dpm) was treated with 10 l
concentrated bacterial supernatant and incubated for 60 min at 37°C. Trypsin (10
g/ml) served as a positive control. Following incubation, respective samples
were mixed with Laemmli sample buffer containing 5% (vol/vol) 2-
-mercapto-
ethanol, boiled for 5 min, separated by SDS-PAGE, and autoradiographed using
a Typhoon 9400 variable mode imager (GE Healthcare) and phosphor storage
screens per the manufacturer’s instructions.
In vivo influenza virus activation. A/Indonesia/5/2005 H5N1 reassortant virus
was treated with bacterial supernatants to determine the effect on influenza virus
infectivity. Uncleaved virus was diluted in PBS to a titer of 3.0  104 PFU/ml,
and 5-l aliquots were incubated with 10 l of the respective concentrated
bacterial supernatants at 37°C for 60 min, followed by layering on MDCK cells
grown in 6-well plates for double-layer overlay analysis (34). Trypsin (2.5 g) was
used as a positive control. After incubation at 37°C for 60 min allowing viral
attachment, the inoculum was removed and the cells were rinsed with PBS. A
1.5-ml trypsin-free VP-SFM 1% (wt/vol) agarose overlay was added to the
monolayer. After 24 h of incubation, a second 1.5-ml agarose overlay (1%
[wt/vol]) containing trypsin (5 g) was added to the wells. After incubation
for 48 to 72 h at 37°C in a 5% (vol/vol) CO2 atmosphere, cells were fixed with
10% (vol/vol) buffered formalin, the agarose layer was removed, and the fixed
cells were stained with 2% (wt/vol) crystal violet in 70% (vol/vol) ethanol
prior to counting. PFU values were determined in triplicate by the method of
Gray (8).
Assay for lipase activity. Lipase activity was determined using API ZYM
substrate assay strips (bioMe´rieux, Inc., Durham, NC). Briefly, 65 l of the
respective supernatant preparations was added to substrate wells, and enzymatic
activity was determined per the manufacturer’s instructions. Phospholipase C
(100 g/ml) from Bacillus cereus (Sigma-Aldrich, St. Louis, MO) was used as a
positive control.
Nucleotide sequence accession numbers. Representative 16S rRNA sequences
have been submitted to GenBank under accession no. GQ478402 to GQ478426.
RESULTS
Identification of protease-secreting bacteria from cloacal
samples. Summarized in Table 1 are the proteolytic activities
of the 44 bacterial isolates found in the cloaca of 67 ducks out
of a total of 112 birds examined. Concentrated bacterial su-
pernatant from Pseudomonas aeruginosa exhibited the most
intense caseinolytic activity, with a clearing zone of 29 mm,
while Staphylococcus aureus exhibited the least intense ca-
seinolytic activity, with a clearing zone of 7 mm (Table 1).
Citrobacter freundii was the only bacterial isolate that exhibited
a localized clouding of the gel (no clear zone of proteolysis). Of
the 67 ducks possessing protease-secreting bacteria, 40 exhib-
ited 2 or more protease-secreting bacteria. Forty-five ducks
were observed to exhibit no protease-secreting bacteria (data
not shown). Of the 44 bacteria identified, 11 were Gram-
positive bacilli, 16 were Gram-positive cocci, and 17 were
Gram-negative bacilli (Table 2). Twenty-two of the 44 isolates
were identified by 16S rRNA sequencing (Table 2). Aeromonas
sobria was the most frequently observed protease-secreting
Gram-negative bacterium isolated from 24 of 67 samples
(36%), while Bacillus pumilus was the most frequently encoun-
tered Gram-positive protease-secreting bacterium (13 samples
constituting 19%) (Table 2).
HA0 cleavage by protease-secreting bacteria isolated from
ducks. Trypsin-like cleavage of HA0 (i.e., the disappearance of
HA0 with the appearance of labeled HA1 and HA2 peptides)
is characteristic of viral activation. Shown in Fig. 1 is repre-
sentative proteolytic conversion of HA0 to HA1 and HA2
peptides (approximately 58 and 26 kDa, respectively [cf. ref-
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erence 24]) observed for 42 of 44 isolates. Trypsin-like conver-
sion of HA0 to HA1 and HA2 peptides varied in band inten-
sity, suggesting different degrees of hydrolysis by the respective
isolates. Two of the 44 isolates appear to promote extensive
proteolysis, as evidenced by complete disappearance of radio-
labeled HA0, with little to no appearance of labeled HA1 and
HA2 peptide bands (Fig. 1, lanes 8 and 10, respectively). Al-
though not the focus of this work, labeled hydrolysate bands
migrating primarily between HA1 and HA2 peptides also dif-
fering in band intensity were also observed.
In vivo assay. In order to assess the effects of HA0 cleavage
by concentrated bacterial supernatants on infectivity of influ-
enza virus, uncleaved virus was treated with all 44 bacterial
supernatants, and MDCK cell monolayers were subsequently
inoculated and double-layer plaque assay analysis carried out
as described by Zhirnov et al. (34). All isolates were evaluated
for toxic effects on MDCK cells. Only one isolate (Pseudomo-
nas aeruginosa) was observed to exhibit deleterious effects on
the monolayer (data not shown). Shown in Fig. 2 are double-
layer in vivo plaque assay analyses corresponding to the 10
HA0 in vitro degradation gel profiles shown in Fig. 1. In vivo
data are listed from highest PFU value (left, isolate 2) to the
lowest PFU value (right, isolate 11). The PBS control (indi-
cated by the dotted line) corresponded to 3.4  103 PFU/ml,
indicating the presence of previously activated virions. Com-
paring the PBS and trypsin controls, the uncleaved viral
stock contained approximately 12% active (i.e., proteolyti-
cally cleaved) HA0. The trypsin control (lane 1, 28,000 PFU)
was in excellent agreement with the viral titer of the beginning
stock (30,000 PFU/ml). Surprisingly, the 10 respective bacterial
supernatants shown in Fig. 2 as well as the 33 profiles not
shown all gave rise to progeny PFU values less than that of the
PBS control (Pseudomonas aeruginosa-treated MDCK cells
exhibited cytopathic effects and were not included). In light of
the less-than-expected background progeny PFU values for
endogenous activated virus following exposure to supernatants
from bacterial isolates, the involvement of some additional
component was suggested.
Lipase assessment. Due to the membrane-enveloped nature
of the influenza virus, we were desirous of examining repre-
sentative isolates which exhibited low PFU values but pro-
nounced trypsin-like cleavage of HA0 for the presence of
lipase activity. Aeromonas sobria and Aeromonas hydrophila
isolates were assayed for lipase activity and observed to exhibit
high levels (4) of esterase (C8) and lipase (C14) activity (data
not shown). Shown in Fig. 3 (lanes 2 and 4) is the effect of these
two bacterial isolate supernatants on trypsin-activated virus.
Post-supernatant incubation plaque counts indicated substan-
tially reduced infectivity compared to the trypsin-only control
(lane 1). Likewise, treatment of trypsin-activated virus with
phospholipase C (lane 3) indicated decreased infectivity
( 80%). As shown in Fig. 4, trypsin-treated, radiolabeled
HA0 treated with phospholipase C and bacterial supernatants
yielded a similar cleavage pattern to that shown in Fig. 1 (lanes
11 and 12), suggesting not only competent HA0 cleavage but
no additional digestion of HA1 and HA2 peptide fragments.
Although endogenous lipase activity could account in part for
lower-than-expected emergent virus following proteolytic acti-
vation, phospholipase C treatment and subsequent reduction
of infectivity are only suggestive and not proof of lipase in-
volvement.
DISCUSSION
We report here that bacterial enzyme secretion mediates
trypsin-like conversion of HA0 to HA1 and HA2 products,
suggestive of influenza virus activation in the cloaca of wild
waterfowl. In general, bacterial supernatants produced zones
of hydrolysis comparable to that of trypsin (19 mm) (Table 1).
Additionally, all bacterial supernatants were evaluated using
PepTag (Promega Corp, Madison, WI) artificial peptide sub-
strates to rule out false positives due to clouding of the agar
medium arising from changes in pH (data not shown). The
TABLE 1. Proteolytic activity of bacterial supernatantsa
Bacterial species Diameter (mm) ofclearing zoneb
Acinetobacter haemolyticus ..........................................................20
Aerococcus viridans ......................................................................14
Aeromonas caviae.........................................................................10
Aeromonas hydrophila..................................................................13
Aeromonas sobria .........................................................................16
Aeromonas veronii ........................................................................13
Bacillus spp. ..................................................................................14
Bacillus amyloliquefaciens ...........................................................15
Bacillus cereus...............................................................................14
Bacillus coagulans ........................................................................13
Bacillus licheniformis....................................................................14
Bacillus megaterium .....................................................................15
Bacillus pumilus............................................................................18
Bacillus subtilis .............................................................................25
Cellulomonas spp. ........................................................................14
Cellulosimicrobium spp................................................................16
Citrobacter freundiic......................................................................16
Enterobacter cloacae ....................................................................20
Enterococcus faecalis....................................................................20
Gemella morbillorum ...................................................................16
Hafnia alvei ...................................................................................16
Klebsiella pneumoniae subsp. pneumoniae ................................17
Kocuria kristinae ...........................................................................19
Kocuria rosea ................................................................................15
Lactococcus lactis subsp. lactis ...................................................23
Lysinibacillus sphaericus ..............................................................11
Microbacterium oxydans...............................................................20
Microbacterium spp. .....................................................................17
Pantoea agglomerans ....................................................................22
Pseudomonas aeruginosa .............................................................29
Pseudomonas alcaligenes .............................................................22
Pseudomonas fluorescens .............................................................23
Raoutella ornithinolytica ..............................................................20
Rhizobium radiobacter .................................................................19
Staphylococcus aureus .................................................................. 7
Staphylococcus cohnii subsp. cohnii ...........................................14
Staphylococcus sciuri ....................................................................14
Staphylococcus warneri ................................................................14
Stenotrophomonas maltophilia ....................................................16
Streptococcus gallolyticus subsp. gallolyticus ..............................14
Streptococcus gallolyticus subsp. pasteurianus ...........................15
Streptococcus hyointestinalis ........................................................16
Streptococcus pneumoniae ...........................................................18
Vibrio vulnificus ............................................................................19
a Protease activity in bacterial supernatants was determined as described in
Materials and Methods.
b Values represent the diameter of the clearing zone on SMCA produced by 10
l concentrated bacterial supernatant material. The trypsin (10 g/ml) control
gave rise to a clearing zone of 19 mm.
c Citrobacter freundii produced a cloudy zone 16 mm in diameter.
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most frequently observed protease-secreting bacterium was
Aeromonas sobria (Table 2). In addition to A. sobria, three
other aeromonad species identified in this study (Aeromonas
caviae, Aeromonas hydrophila, and Aeromonas veronii) have
previously been isolated from wild waterfowl (1). Several spe-
cies belonging to the genus Bacillus were isolated, with B.
pumilus observed in all ducks, except green-winged teal (Table
2). Numerous proteolytic isolates of Enterobacter cloacae were
encountered, as were isolates of Kocuria kristinae (formerly
Micrococcus kristinae) and Cellulosimicrobium (formerly as-
signed to the genera Oerskovia and Nocardia).
Radiolabeled HA0 was cleaved in a trypsin-like manner to
various degrees by supernatants from 42 of 44 duck cloacal
isolates. Although, trypsin-like cleavage was observed, addi-
tional analysis of HA1 and HA2 peptides is required in order
to rule out the possibility that small alterations arising from
incorrect cleavage initially and/or subsequent removal of resi-
dues have not occurred resulting in loss of function and thus
lower-than-expected in vivo infectivity data. Bacillus pumilus
and Cellulosimicrobium spp. secreted proteases that extensively
degraded the HA0 glycoprotein and HA1 and HA2 peptide
hydrolysis products.
Utilization of MDCK cell monolayers and the double-over-
lay plaque assay as described by Zhirnov and coworkers (34)
TABLE 2. Summary of protease-secreting bacteria identified from wild ducksa
Bacterial species
No. of isolates fromb:
All ducks
(n  112)
Mallards
(n  64)
BWT
(n  32)
Pintails
(n  9)
GWT
(n  7)
Gram negative
Acinetobacter haemolyticus 2 0 1 0 1
Aeromonas caviae 5 0 4 0 1
Aeromonas hydrophila 13 0 13 0 0
Aeromonas sobria 24 1 18 3 2
Aeromonas veronii 8 0 7 1 0
Citrobacter freundii 2 0 2 0 0
Enterobacter cloacae 15 9 4 2 0
Hafnia alvei 6 1 5 0 0
Klebsiella pneumoniae subsp. pneumoniae 1 1 0 0 0
Pantoea agglomerans 4 1 1 0 2
Pseudomonas aeruginosa 4 1 0 1 2
Pseudomonas alcaligenes 2 0 1 0 1
Pseudomonas fluorescens 4 1 0 1 2
Raoultella ornithinolytica 1 0 1 0 0
Rhizobium radiobacter 2 1 0 1 0
Stenotrophomonas maltophilia 1 1 0 0 0
Vibrio vulnificus 2 0 2 0 0
Gram positive
Aerococcus viridans 1 0 1 0 0
Bacillus spp. 4 2 (2) 1 (1) 0 1 (1)
Bacillus amyloliquefaciens 3 0 3 0 0
Bacillus cereus 3 3 0 0 0
Bacillus coagulans 2 0 0 0 2
Bacillus licheniformis 2 0 2 (2) 0 0
Bacillus megaterium 9 1 7 0 1
Bacillus pumilus 13 3 9 1 0
Bacillus subtilis 1 1 0 0 0
Cellulomonas spp. 1 0 1 (1) 0 0
Cellulosimicrobium spp. 10 2 (2) 7 (7) 0 1 (1)
Enterococcus faecalis 1 1 0 0 0
Gemella morbillorum 6 5 1 0 0
Kocuria kristinae 11 6 2 0 3
Kocuria rosea 3 1 0 1 1
Lactococcus lactis subsp. lactis 1 0 1 0 0
Lysinibacillus sphaericus 1 0 1 (1) 0 0
Microbacterium oxydans 1 0 1 0 0
Microbacterium spp. 4 0 1 (1) 1 (1) 2 (2)
Staphylococcus aureus 1 0 0 1 0
Staphylococcus cohnii subsp. cohnii 1 0 1 0 0
Staphylococcus sciuri 1 0 1 0 0
Staphylococcus warneri 1 0 1 0 0
Streptococcus gallolyticus subsp. gallolyticus 3 3 0 0 0
Streptococcus gallolyticus subsp. pasteurianus 1 1 0 0 0
Streptococcus hyointestinalis 2 2 0 0 0
Streptococcus pneumoniae 2 1 0 0 0
a Protease-secreting bacteria from free-range ducks were identified as described in Materials and Methods.
b BWT, blue-winged teal; GWT, green-winged teal. Numbers in parentheses indicate isolates identified by 16S RNA sequence analysis.
4122 KING ET AL. APPL. ENVIRON. MICROBIOL.
 o
n
 Septem
ber 11, 2018 by guest
http://aem
.asm
.org/
D
ow
nloaded from
 
simulated conditions similar to that of the lower gastrointesti-
nal tract of birds, eliminating (i) trypsin activation of viral
particles as is the case for standard plaque assays and (ii)
proteases found in the allantoic fluid of embryonated chicken
eggs (7), enzymes not found in distal portions of the avian
intestinal tract (21). Thus, activation of virus arose solely from
proteolytic cleavage by the bacterial supernatant. Interestingly,
virus stock used for in vivo experiments contained cleaved HA0
(12%), which proved advantageous in that the negative effect
of bacterial supernatants on these cleaved (i.e., activated) vi-
rions was observed and assessed (Fig. 2). Despite producing a
trypsin-like cleavage pattern, plaque counts less than that of
the control, which contained cleaved (i.e., activated) virions,
were observed for all isolates tested.
FIG. 1. SDS-PAGE analysis of polypeptide fragment patterns ob-
tained following incubation of HA0 with supernatant material from
protease-secreting bacterial isolates. [35S]HA0 was incubated with bac-
terial supernatant material for 60 min, subjected to SDS-PAGE anal-
ysis, and autoradiographed as described in Materials and Methods.
Lanes: 1, PBS negative control; 2, trypsin, 10 g/ml; 3, Streptococcus
hyointestinalis (isolate 95-11); 4, Aerococcus viridans (isolate 135-8); 5,
Lysinibacillus sphaericus (isolate 135-12); 6, Bacillus amyloliquefaciens
(isolate 135-4); 7, Kocuria kristinae (isolate 107-14); 8, Bacillus pumilus
(isolate 136-9); 9, Enterobacter cloacae (isolate 99-3); 10, Cellulosimi-
crobium sp. (isolate 111-15); 11, Aeromonas sobria (isolate 124-1); 12,
Aeromonas hydrophila (isolate 119-3). The numbered arrows indicate
the established molecular masses for HA0 and trypsin hydrolysis prod-
ucts HA1 and HA2 (80, 58, and 26 kDa, respectively) (24).
FIG. 2. Infectivity of influenza A/Indonesia/5/2005(H5N1) virus
following incubation with concentrated supernatants from duck cloacal
bacterial isolates. Uncleaved influenza A/Indonesia/5/2005 (H5N1) vi-
rus was incubated with respective bacterial supernatants for 60 min
followed by layering onto MDCK monolayers for double-layer plaque
assay analysis as described in Materials and Methods. Lanes: 1, trypsin,
10 g/ml; 2, Lysinibacillus sphaericus (isolate 135-12); 3, Streptococcus
hyointestinalis (isolate 95-11); 4, Aerococcus viridans (isolate 135-8); 5,
Bacillus amyloliquefaciens (isolate 135-4); 6, Kocuria kristinae (isolate
107-14); 7, Enterobacter cloacae (isolate 99-3); 8, Aeromonas hydrophila
(isolate 119-3); 9, Bacillus pumilus (isolate 136-9); 10, Cellulosimicro-
bium sp. (isolate 111-15); 11, Aeromonas sobria (isolate 124-1). The
dotted line represents the PBS control (3.4  103 PFU/ml).
FIG. 3. Infectivity of trypsin-activated influenza A/Indonesia/5/
2005(H5N1) virus following incubation with supernatant material from
two lipase-secreting cloacal bacteria isolates. Trypsin-treated influenza
A/Indonesia/5/2005 (H5N1) virus was incubated with bacterial super-
natants for 60 min, followed by layering onto MDCK monolayers for
double-layer plaque assay analysis as described in Materials and Meth-
ods. Lanes: 1, trypsin-only control (10 g/ml); 2, supernatant material
from Aeromonas hydrophila (isolate 119-3); 3, phospholipase C-only
control (100 g/ml); 4, supernatant material from Aeromonas sobria
(isolate 124-1).
FIG. 4. SDS-PAGE analysis of polypeptide fragment patterns
obtained following incubation of trypsin-activated [35S]HA0 with
supernatant material from two lipase-secreting cloacal bacterial
isolates. Preparation of radiolabeled HA0, HA0 cleavage with tryp-
sin, SDS-PAGE analysis, and autoradiography were carried out as
previously described in Materials and Methods. Lanes: 1, [35S]HA0,
untreated; 2, trypsin-only control (10 g/ml); 3, phospholipase C-
only control (100 g/ml); 4, supernatant material from Aeromonas
sobria (isolate 124-1); 5, supernatant material from Aeromonas hy-
drophila (isolate 119-3). The superscripted numbered arrows indi-
cate the established molecular masses for HA0 and trypsin hydro-
lysis products HA1 and HA2 (80, 58, and 26 kDa, respectively) (24).
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Because influenza virus is surrounded by a membrane enve-
lope, we examined the possible presence of lipolytic activity in
two isolates that exhibited a pronounced trypsin-like hydrolysis
pattern but reduced infectivity of endogenous activated virus.
Esterase (C8) and lipase (C14) activities were observed in both
isolates. As shown in Fig. 3, trypsin-activated virions incubated
with supernatants from these two bacterial isolates (lanes 2 and
4) or phospholipase C (lane 3) gave rise to significantly re-
duced plaque formation compared to that of the trypsin con-
trol (lane 1), albeit higher than that observed following treat-
ment of influenza virus with supernatants from these two
isolates as shown in Fig. 2, lanes 8 and 11. Trypsin-treated
radiolabeled HA0 incubated with these bacterial isolate super-
natants or phospholipase C (Fig. 4, lanes 3, 4, and 5) exhibited
trypsin-like cleavage patterns similar to those previously ob-
served (Fig. 1, lanes 11 and 12), suggesting that activation (i.e.,
cleavage of HA0 to HA1 and HA2 peptides) occurred. How-
ever, due to the complex nature of these bacterial superna-
tants, the lack of predicted infectivity could arise from con-
tributors other than proteases either individually or in
combination. For example, removal of membrane components
as well as specific sugars from the HA0 glycoprotein by glyco-
sidases present in the bacterial supernatants could also occur,
resulting in decreased infectivity. 
-Galactosidase, 	-mannosi-
dase, and N-acetyl-
-glucosaminidase activities were observed
in these isolates (data not shown). Thus, disruption of the viral
membrane or incorrect proteolytic cleavage, as well as possible
removal of sugars required for viral binding to the cell
surface receptor, could account for the observed disparate
surveillance numbers between virus isolation and real-time
PCR (6, 20, 22). Higher rates of detection are associated
with molecular screening methods than with cultured sam-
ples because PCR detects viral RNA from both viable as
well as nonviable viruses (15).
Previous studies of influenza virus and coinfecting proteo-
lytic bacteria in the respiratory tract demonstrated Aerococcus
viridans, Staphylococcus aureus, and Stenotrophomonas malto-
philia to activate influenza virus in vivo (16, 23, 30, 31). We also
observed these three organisms in the avian lower digestive
tract. As indicated in Fig. 1 and 2 (lane 4), Aerococcus viridans
exhibited the expected HA1 and HA2 hydrolysis products but
with infectivity (PFU/ml) values less than that of the PBS
control, like that of Staphylococcus aureus and Stenotrophomo-
nas maltophilia (data not shown).
In the present study, we describe identification of protease-
secreting bacteria from the gastrointestinal tracts of different
waterfowl and their capability to cleave HA0 both in vitro and
in vivo. Despite producing trypsin-like cleavage patterns con-
sistent with that of viral activation, none of these isolates
gave rise to expected progeny virus. Thus, the contribution
of microbial proteases to influenza virus activation and
other bacterially derived activities (e.g., lipase) to virus in-
activation warrants further research.
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